Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

An Observational Clinical Research Study Assembling and Analyzing Highly Complex, Multi-dimensional Molecular and Clinical Data With a Focus on High-risk Diabetes Patients in South Carolina, in Support of the Biomedical Research Initiative for Scientific Knowledge (BRISK)

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The primary purpose of this study is to use multiomic data in combination with clinical assessments, electronic health records, cognitive and mood assessments, wearable technologies and lifestyle/behavioral data to identify data elements or combinations of data elements with strong positive or negative correlation to CKD diagnosis and/or progression in Type 2 Diabetes (T2D) patients. Achieving this aim will allow researchers and physicians to significantly improve the prediction of health trajectories of and formulate novel strategies to potentially prevent, treat or reverse T2D. South Carolina Medicaid-enrolled patients diagnosed with T2D and a smaller subset of non-T2D SC Medicaid patients may participate in this study. Participants who complete required procedures will be compensated for their time and transportation, may keep their study-provided Fitbit device to help maintain their healthcare improvement journey, and will have a personal Certified Diabetes Educator to consult and assist with managing their diabetes diagnosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 70
Healthy Volunteers: t
View:

⁃ All Participants:

• 40 to 70 years of age (inclusive) at enrollment

• Enrolled as Medicaid recipients

• Ability to provide informed consent and authorization for release of relevant protected health information or personal data

• Ability to provide a blood sample(s) of up to 70 mL and other required biospecimens, including genetic samples.

⁃ T2D Group:

⁃ • Current diagnosis of Type 2 diabetes OR a blood level of hemoglobin A1c equal to or greater than 6.5% at any time within the past 12 months

⁃ Control Group:

• Blood level of hemoglobin A1c less than or equal to 5.6% at time of enrollment

• No diagnosis of Type 2 diabetes

Locations
United States
South Carolina
Clemson Health Clinic at Orangeburg
RECRUITING
Orangeburg
Clemson Health Clinic at Walhalla
RECRUITING
Walhalla
Time Frame
Start Date: 2026-08
Estimated Completion Date: 2029-10
Participants
Target number of participants: 1200
Treatments
Type 2 Diabetes
SC Medicaid-enrolled Type 2 Diabetes Patients
Healthy Controls
SC Medicaid-enrolled non-T2D Patients
Related Therapeutic Areas
Sponsors
Collaborators: South Carolina Department of Health and Human Services, Spartanburg Regional Healthcare System
Leads: Guardian Research Network, Inc.

This content was sourced from clinicaltrials.gov